ZNF436 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.286200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.178400E-01
Normal-vs-Stage2
1.051580E-01
Normal-vs-Stage3
2.085200E-01
Normal-vs-Stage4
7.474000E-01
Stage1-vs-Stage2
7.397600E-01
Stage1-vs-Stage3
1.661810E-01
Stage1-vs-Stage4
4.418600E-01
Stage2-vs-Stage3
4.361200E-03
Stage2-vs-Stage4
2.029400E-01
Stage3-vs-Stage4
1.194160E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.400200E-02
Normal-vs-AfricanAmerican
5.344400E-01
Normal-vs-Asian
2.040400E-01
Caucasian-vs-AfricanAmerican
2.713200E-01
Caucasian-vs-Asian
8.923800E-01
AfricanAmerican-vs-Asian
4.504200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.969900E-02
Normal-vs-Female
9.226300E-02
Male-vs-Female
6.750600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.936600E-01
Normal-vs-Age(41-60Yrs)
3.217800E-01
Normal-vs-Age(61-80Yrs)
3.909700E-02
Normal-vs-Age(81-100Yrs)
2.292200E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.351600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.477200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.032200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.590000E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.217700E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.309800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.795900E-02
Normal-vs-Daily Drinker
1.707920E-02
Normal-vs-Weekly Drinker
9.017800E-02
Normal-vs-Occasional Drinker
1.700220E-01
Normal-vs-Social Drinker
3.662400E-01
Non Drinker-vs-Daily Drinker
7.217000E-01
Non Drinker-vs-Weekly Drinker
6.376400E-01
Non Drinker-vs-Occasional Drinker
2.705400E-01
Non Drinker-vs-Social Drinker
1.917780E-01
Daily Drinker-vs-Weekly Drinker
4.057400E-01
Daily Drinker-vs-Occasional Drinker
1.441200E-01
Daily Drinker-vs-Social Drinker
1.610600E-01
Weekly Drinker-vs-Occasional Drinker
5.930000E-01
Weekly Drinker-vs-Social Drinker
4.551000E-01
Occasional Drinker-vs-Social Drinker
7.352800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.089600E-01
Normal-vs-Grade 2
4.640000E-01
Normal-vs-Grade 3
8.715800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.656200E-02
Grade 1-vs-Grade 3
2.762800E-01
Grade 1-vs-Grade 4
9.089600E-01
Grade 2-vs-Grade 3
9.734300E-02
Grade 2-vs-Grade 4
4.640000E-01
Grade 3-vs-Grade 4
8.715800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.868500E-02
Normal-vs-NonDiabetic
7.990500E-02
Diabetic-vs-NonDiabetic
4.705600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.858300E-02
Normal-vs-NoPancreatitis
7.514000E-02
Pancreatitis-vs-NoPancreatitis
5.714000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.494300E-02
Normal-vs-N1
1.130440E-01
N0-vs-N1
4.856100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.968500E-02
Normal-vs-TP53-NonMutant
1.435950E-01
TP53-Mutant-vs-TP53-NonMutant
7.241600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
